Interventional Cardiology. Группа авторов

Femoral artery access techniques to prevent vascular complications Vascular closure devices for femoral access Vascular closure devices in procedures using large bore sheaths Complications associated with vascular closure devices Radial artery related complications References CHAPTER 28: Renal Insufficiency and the Impact of Contrast Agents Contrast‐associated acute kidney injury Conclusion References CHAPTER 29: Radiation Management in Interventional Cardiology Measurements of radiation Radiobiology Patient radiation management Staff radiation safety Specific radiation safety considerations Pediatric patients Training and education Conclusions References CHAPTER 30: Concepts of Cell Therapy and Myocardial Regeneration References SECTION VI: Clinical Trials in Coronary Heart Disease CHAPTER 31: Durable Polymer Everolimus Eluting Stents Stent platform properties of DP‐EES Polymer biocompatibility of DP‐EES Drug: Everolimus Xience CoCr DP‐EES: clinical trials Promus PtCr DP‐EES: clinical trials References CHAPTER 32: Bioresorbable‐polymer Everolimus‐eluting Stents Introduction Biocompatibility: surface characteristics and resistance to corrosion Longitudinal stent deformation and the role of stent architecture Drugs Synergy EES Clinical trials Special groups All comer trials Meta‐analysis Future perspectives Evermine 50^TM Clinical trials Conclusions References CHAPTER 33: Zotarolimus‐Eluting Stents Technical features Clinical findings Conclusions References CHAPTER 34: The Biolimus Stent Family Biolimus The Biosensor stent family The Nobori stent References CHAPTER 35: The Biotronik Stent Family Cobalt chromium platform Passive coating PRO‐Kinetic Energy Orsiro Absorbable metal scaffolds PK Papyrus stent References CHAPTER 36: Novel Drug‐Eluting Stent Systems Metallic platforms Antiproliferative agents Polymer coatings and alternative drug release technologies Future perspectives Conclusions References CHAPTER 37: Cardiac Vein Anatomy and Transcoronary Sinus Catheter Interventions in Myocardial Ischemia Aims of transcoronary sinus interventions Anatomy of cardiac veins Pathophysiologic background of transcoronary sinus interventions How to access jeopardized myocardium Current transcoronary sinus catheter interventions in myocardial jeopardy PICSO Conclusions and future directions References

      10  PART II: Interventional Pharmacology CHAPTER 38: Basics of Antiplatelet and Anticoagulant Therapy for Cardiovascular Disease Role of platelets and coagulation factors in thrombus formation Overview of antiplatelet agents for atherosclerotic diseases Phosphodiesterase inhibitors PAR‐1